Search Results

• Arnold Palmer Invitational- March 5-8, 2020

  Arnold Palmer Invitational presented by Mastercard is a proud supporter of Arnie’s Army Charitable Foundation. Arnie’s Army is marching toward a better tomorrow. We believe it is our mission to invest in the health, well-being and development of children and youth. We believe that Arnie’s Army is united behind something stronger than ourselves. These “beliefs” are core to the foundational fabric of Arnie’s Army. 

• Children’s Brain Tumor Network (CBTN) Collection Protocol

  Children’s Brain Tumor Network (CBTN) Collection Protocol

• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

• The Association of Kawasaki Disease and COVID-19 with Cardiac Complications:

  The Association of Kawasaki Disease and COVID-19 with Cardiac Complications: A Focused Sub-study of the International Kawasaki Disease Registry (IKDR)

• DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma

• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects with Moderately to Severely Active Ulcerative Colitis

• A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

  4202-HEM-301: An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)

• Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors (Explorer10)

  Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors

• Investigation Drug Study to Assess the Efficacy and Safety of NEXIUM for Treating Erosive Esophagitis

  A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years

• Beat Childhood Cancer Specimen Banking and Data Registry

  Specimen Banking With Clinical and Genomic Data Registry With the Establishment of Tumor Models for Pediatric Cancers